Abstract:Adult spinal deformity (ASD) treatment for patients with osteoporosis presents a unique challenge for spine surgeons, particularly with ensuring adequate fixation and correction during surgery and due to the risk of treatment failure and complications thereafter. Osteoporosis is characterized by low bone mineral density (BMD) which may increase the risk for fractures. Approximately 12.6% of all adults over 50 years old in the United States are affected by osteoporosis, and the prevalence is predicted to increase with the aging population.1 ASD patients experience substantially higher rates of osteoporosis compared to the general population.2,3 One study discovered an osteoporosis prevalence of nearly 33% in a cohort of ASD patients undergoing long spinal fusion at two academic medical centers, with slightly over one- third of those patients receiving osteoporosis pharmacotherapy prior to surgery.3 Similarly, patients with osteoporosis experience ASD at higher rates than the general population, with one study finding that 9.5% of patients with osteoporosis suffer from ASD symptoms.3 Gupta et al. discovered that obtaining a DEXA scan of the forearm in addition to the hip allowed physicians to detect an additional 17% incidence of osteoporosis in ASD patients, suggesting that osteoporosis may be missed when there is only one DEXA scan available.4In addition to being potentially underdiagnosed and undertreated, ASD patients with osteoporosis experience higher rates of post-surgical complications. Pseudarthrosis, or nonunion after spinal fusion, is a painful and potentially debilitating complication following ASD surgery that ultimately requires additional surgical correction. Proximal junctional kyphosis (PJK), which is defined as proximal junctional sagittal Cobb angle ≥ 10° and at least 10° greater than the preoperative measurement, is another complication of ASD surgery.5 Though this condition may be clinically silent and manifest purely as a radiographic diagnosis, it is often a precursor to proximal junctional failure (PJF), a more severe form of PJK that ultimately increases the risk for intractable pain, neurological deficit, and revision surgery.6 ASD patients with osteoporosis experience significantly higher rates of pseudarthrosis, PJK, PJF, and postoperative fractures, as well as other forms of instrumentation failure requiring additional surgical treatment.7-11 This ultimately increases the pain, emotional burden, and morbidity experienced by patients. There is currently conflicting data regarding the impact of perioperative osteoporosis pharmacotherapy on outcomes in ASD patients. Bisphosphonates are considered first-line treatment for osteoporosis, though alternatives such as teriparatide, denosumab, and calcitonin may be used as well.12 Multiple studies have found that preoperative bisphosphonate treatment did not affect lumbar fusion nonunion rates.13,14 In contrast, a meta-analysis of randomized control trials found that postoperative bisphosphonates had no effect on lumbar fusion rates but did significantly reduce the risk of vertebral compression fracture (VCF) and pedicle screw loosening at 12-month follow-up.15 Prophylactic teriparatide treatment has been associated with improved BMD and lower incidence of PJK type-2 in osteoporosis patients who underwent ASD surgery.16 Evidence for perioperative treatment of teriparatide as a preventative step to increase fusion rates and reduce PJK and PJF is strongest.17 However, the percentage of ASD patients who are actually being treated perioperatively with these medications requires further evaluation, and a comparison of outcomes with osteoporosis and non-osteoporosis counterparts has yet to be explored. The purpose of this study was to evaluate the prevalence and treatment of osteoporosis among patients undergoing long spinal fusion for ASD, as well as compare the impact of osteoporosis treatment on surgical and radiographic outcomes following fusion surgery. Additionally, we sought to examine the differences in radiographic outcomes of osteoporotic patients receiving various pharmacologic regimens such as monotherapy vs combination therapy.

Effect of bisphosphonates or teriparatide on mechanical complications after posterior instrumented fusion for osteoporotic vertebral fracture: a multi-center retrospective study

Clinical Effect of PKP in Treatment of Patients with Multi-segmental Osteoporotic Vertebral Compressive Frac-tures

Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment

Effectiveness of Teriparatide for Spine Fusion in Osteoporotic Patient: A Systematic Review and Meta-Analysis of Comparative Studies

Study on the Relationship between the Use of Bisphosphonates for Antiosteoporosis and Vertebral Re-Fracture after Vertebroplasty

Impact of Teriparatide and Denosumab on Clinical and Radiographic Outcomes in Osteoporotic Vertebral Compression Fractures

The influence of osteoporosis on mechanical complications in lumbar fusion surgery: a systematic review

Effect of low body mass index on clinical recovery after fusion surgery for osteoporotic vertebral fracture: A retrospective, multicenter study of 237 cases

The effect of osteoporotic treatment on the functional outcome, re-fracture rate, quality of life and mortality in patients with hip fractures: a prospective functional and clinical outcome study on 520 patients

Is Teriparatide Superior in Treating Osteoporotic Vertebral Compression Fractures in Comparison to Bisphosphonates Treatment Alone: A 2-Year Retrospective Analysis

The Effect of Teriparatide on Fracture Healing of Osteoporotic Patients: A Meta-Analysis of Randomized Controlled Trials

The Efficiency of Antiosteoporosis Medicine after Intertrochanteric Fracture Surgery: A Retrospective Study of Refracture Rate, Function Recovery, Complications, and Mortality in the Chinese Elderly Population

Effect of anti-osteoporotic drugs in reducing risk of refracture after percutaneous vertebroplasty

Teriparatide Associated with Fewer Refractures and Higher Body Heights of Cemented Vertebrae after Vertebroplasty: A Matched Cohort Study

Comparison of the Clinical Efficacy of Anabolic Agents and Bisphosphonates in the Patients With Osteoporotic Vertebral Fracture: Systematic Review and Meta-analysis of Randomized Controlled Trials

The Effect of Daily Teriparatide versus One-Time Annually Zoledronic Acid Administration After Transforaminal Lumbar Interbody Fusion in Osteoporotic Patients

Surgical outcomes of spinal fusion for osteoporotic thoracolumbar vertebral fractures in patients with Parkinson’s disease: what is the impact of Parkinson’s disease on surgical outcome?

Survey on Actual Management of Osteoporosis with the Japanese Medical Data Vision Database in Elderly Patients Undergoing Spinal Fusion

Effectiveness and Safety of Vertebral Body Stenting for Acute Spinal Compression Fractures due to Primary Osteoporosis: A Multicenter Prospective Clinical Study

Osteoporosis Treatment and Outcomes in Patients Undergoing Adult Spinal Deformity Surgery

Therapeutic effect of percutaneous kyphoplasty combined with anti-osteoporosis drug on postmenopausal women with osteoporotic vertebral compression fracture and analysis of postoperative bone cement leakage risk factors: a retrospective cohort study